Showing 271 results
Archival DescriptionCorrespondence, notes and application for Health Technology Assessment (HTA) grant for Credibility of HTA results for new chronic disease therapies : a case study of MS drugs
Correspondence, notes and application for Health Technology Assessment (HTA) grant for Credibility of HTA results for new chronic disease therapies : a case study of MS drugs
Correspondence, notes, drafts and tables for a study on the impact of universal medicare on the previously insured poor and non-poor
Correspondence, notes, drafts and tables for a study on the impact of universal medicare on the previously insured poor and non-poor
Cost of multiple sclerosis study correspondence, data tables and notes
Cost of multiple sclerosis study correspondence, data tables and notes
Cost of multiple sclerosis study meeting minutes with appendices on costing methods and plans
Cost of multiple sclerosis study meeting minutes with appendices on costing methods and plans
Cost of multiple sclerosis study proposal, notes and correspondence
Cost of multiple sclerosis study proposal, notes and correspondence
Cost of multiple sclerosis study research presentations for symposiums, offprint, data entry forms
Cost of multiple sclerosis study research presentations for symposiums, offprint, data entry forms
Cost of multiple sclerosis study tables, notes and correspondence
Cost of multiple sclerosis study tables, notes and correspondence
Cost of multple sclerosis study correspondence, data tables, research notes, reports, abstracts and meeting notes
Cost of multple sclerosis study correspondence, data tables, research notes, reports, abstracts and meeting notes
Cost-effectiveness : the case of home health care physician services in New Brunswick, Canada
Cost-effectiveness : the case of home health care physician services in New Brunswick, Canada
Cost-effectiveness and cost-effectiveness-acceptibility-curves for therapies that slow disability progression in relapsing-remitting multiple sclerosis : simulations for US and Canadian markets - draft report and correspondence for Aventis Pharmaceuticals
Cost-effectiveness and cost-effectiveness-acceptibility-curves for therapies that slow disability progression in relapsing-remitting multiple sclerosis : simulations for US and Canadian markets - draft report and correspondence for Aventis Pharmaceuticals
Cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis - DO files
Cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis - DO files
Cost-effectiveness of Interferon Beta-1B in slowing multiple sclerosis disability progression : first estimates
Cost-effectiveness of Interferon Beta-1B in slowing multiple sclerosis disability progression : first estimates
Cost-effectiveness of MS DMDs in Nova Scotia - abstract, tables, draft stucture, notes
Cost-effectiveness of MS DMDs in Nova Scotia - abstract, tables, draft stucture, notes
Cost-effectiveness of multiple sclerosis - DMT report and notes
Cost-effectiveness of multiple sclerosis - DMT report and notes
Cost-effectiveness of multiple sclerosis drugs in the "real world"
Cost-effectiveness of multiple sclerosis drugs in the "real world"
Cost-effectiveness of multiple sclerosis therapies - appendix A drafts
Cost-effectiveness of multiple sclerosis therapies - appendix A drafts
Cost-effectiveness of multiple sclerosis therapies - notes, draft tables and figures
Cost-effectiveness of multiple sclerosis therapies - notes, draft tables and figures
Cost-effectiveness of new multiple sclerosis therapies reference list
Cost-effectiveness of new multiple sclerosis therapies reference list
Costs of managing patients at a Canadian rheumatic disease unit - off print
Costs of managing patients at a Canadian rheumatic disease unit - off print
CVs
CVs
Dalhousie cholesterol interventions projections project HECON report
Dalhousie cholesterol interventions projections project HECON report
Dalhousie MS research group evaluation studies 1994-2009
Dalhousie MS research group evaluation studies 1994-2009
Dalhousie MS Research Group meeting minutes
Dalhousie MS Research Group meeting minutes
Dalhousie MS Research Unit annual report
Dalhousie MS Research Unit annual report
Dalhousie University computer output files on Nova Scotia physician earnings and population estimates
Dalhousie University computer output files on Nova Scotia physician earnings and population estimates
Dalhousie/Capital Health appointments
Dalhousie/Capital Health appointments
Description of EMH data files (on 3 1/2 inch disks)
Description of EMH data files (on 3 1/2 inch disks)
Disability progression in MS measured by means, medians and survival distribution functions - submission abstract to International Society For Pharmacoeconomics and Outcomes Research congress, notes, tables, appendices, correspondence and data tables
Disability progression in MS measured by means, medians and survival distribution functions - submission abstract to International Society For Pharmacoeconomics and Outcomes Research congress, notes, tables, appendices, correspondence and data tables
Disability progression in multiple sclerosis is faster than observed
Disability progression in multiple sclerosis is faster than observed
Disease-modifying drugs and multiple sclerosis research notes, drafts and data tables
Disease-modifying drugs and multiple sclerosis research notes, drafts and data tables
Do cost-effective programs reduce costs? - notes
Do cost-effective programs reduce costs? - notes
Do Kaplan-Meier models underestimate MS disability progression speed when populated with observational data - Community Health and Epidemiology Series presentation, synopsis, notes, data
Do Kaplan-Meier models underestimate MS disability progression speed when populated with observational data - Community Health and Epidemiology Series presentation, synopsis, notes, data
Economic consequences of chronic illness - presentation notes
Economic consequences of chronic illness - presentation notes
Economic evaluation of Extracorporeal Shock Wave Lithotripsy (ESWL) in treating kidney stones - draft reports, correpondence, tables, study questionnaire, secondary literature, presentation slides
Economic evaluation of Extracorporeal Shock Wave Lithotripsy (ESWL) in treating kidney stones - draft reports, correpondence, tables, study questionnaire, secondary literature, presentation slides
EDSS natural history atlas : multiple sclerosis disability progression in Nova Scotia, 1979-2004
EDSS natural history atlas : multiple sclerosis disability progression in Nova Scotia, 1979-2004
EDSS survival analysis notes, life-table survival function estimate
EDSS survival analysis notes, life-table survival function estimate
Effectiveness and cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis : tables and graphs
Effectiveness and cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis : tables and graphs
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world"
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world"
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world" : final report
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world" : final report
Effectiveness and cost-effectiveness of new muliple sclerosis drugs in the "real world" - research grant application to Multiple Sclerosis Society of Canada and correspondence regarding accounts and research ethics
Effectiveness and cost-effectiveness of new muliple sclerosis drugs in the "real world" - research grant application to Multiple Sclerosis Society of Canada and correspondence regarding accounts and research ethics
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world'
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world'
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the "real world"
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the "real world"
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the real world - correspondence re. data transfer/analysis request, data tables, and 2001 proposal to Health Policy Research Program
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the real world - correspondence re. data transfer/analysis request, data tables, and 2001 proposal to Health Policy Research Program
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world' - draft reports with corrections
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world' - draft reports with corrections
Effectiveness and cost-effectiveness of new multiple sclerosis drugs the "real world" : final report to Health Policy Research Program, Health Canada
Effectiveness and cost-effectiveness of new multiple sclerosis drugs the "real world" : final report to Health Policy Research Program, Health Canada
Effectiveness of disease modifying agents in multiple sclerosis : a longitudinal population based comparison - presentation, notes and tables
Effectiveness of disease modifying agents in multiple sclerosis : a longitudinal population based comparison - presentation, notes and tables
Effectiveness of disease-modifying MS drugs in delaying progression in the 'real world' - draft abstracts, working paper, tables and notes
Effectiveness of disease-modifying MS drugs in delaying progression in the 'real world' - draft abstracts, working paper, tables and notes
Effects of a global budget for physician services on claiming patterns to Workers Compensation Board
Effects of a global budget for physician services on claiming patterns to Workers Compensation Board
Effects of capping global expenditures and individual practice incomes in Nova Scotia
Effects of capping global expenditures and individual practice incomes in Nova Scotia
Email between Sarah Kirby and Murray Brown regarding modelling for research on drug efficacy in delaying disability progression in relapsing remitting onset MS
Email between Sarah Kirby and Murray Brown regarding modelling for research on drug efficacy in delaying disability progression in relapsing remitting onset MS
Results 51 to 100 of 271